NovaBay Pharma (NBY) stock underwent a massive rally on Wednesday after the biopharmaceutical company announced a special one-time cash dividend. Investors in NBY stock will receive 80 cents per share. This dividend is payable September 29, 2025 to shareholders on record as of the close of business on September 15, 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
NovaBay Pharma noted that there are special restrictions on the dividend. Due to its size, more than 25% of the value of NBY stock, NYSE American has said its stock will trade with due bills. This creates a Dividend Right Period lasting from September 15, 2025 through September 29, 2025. Shareholders who sell their NBY stock during this time will forfeit their right to the special cash dividend.
David Lazar, CEO of NovaBay Pharma, said, “This special dividend reflects our commitment to creating and returning value directly to our stockholders. I’m excited about the Company’s future as we explore several interesting strategic alternatives.”
NovaBay Pharma Stock Movement Today
NovaBay Pharma stock was up 91.33% on Wednesday, following a slight dip yesterday. The shares have rallied 49.83% year-to-date and 80.15% over the past 12 months. With today’s dividend news came heavy trading of NBY stock. This saw more than 59 million shares traded, compared to a three-month daily average of about 6.47 million units.
Is NovaBay Pharma Stock a Buy, Sell, or Hold?
Turning to Wall Street, coverage of NovaBay Pharma is thin. Fortunately, TipRanks’ AI analyst Spark has it covered. Spark rates NBY stock a Neutral (55) with a price target of $1. It cites “significant financial challenges, including declining revenues and negative profit margins” as reasons for this stance.
